Generic medicine

Tranexamic Acid 500mg Tablet

Reviewed educational reference: what Tranexamic Acid is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.

Reviewed by Sohan Lal Kushwaha
Molecule
Tranexamic Acid
Strength
500mg
Dosage form
Tablet
Drug class
Antifibrinolytic agent

Related products

No reviewed products are currently published for this generic.

Tranexamic acid is a potent synthetic antifibrinolytic agent used to manage and prevent excessive bleeding. By inhibiting the breakdown of fibrin clots, it helps stabilize the haemostatic process in various clinical scenarios, including heavy menstrual bleeding and surgical procedures. It is a cornerstone therapy for patients requiring controlled haemostasis.

At a glance

Quick look

Tranexamic Acid 500mg Tablet contains Tranexamic acid, a synthetic antifibrinolytic.

How it works

It prevents the breakdown of blood clots to manage excessive bleeding.

Who it is for

It is used for heavy menstrual bleeding and surgical haemostasis.

Uses it for
MenorrhagiaDental surgeryTraumaEpistaxisHereditary angioedemaSurgical blood loss

Uses of Tranexamic Acid

  • Treatment of heavy menstrual bleeding (menorrhagia)
  • Prevention of bleeding in patients with haemophilia undergoing dental surgery
  • Management of hereditary angioedema
  • Reduction of blood loss during major surgical procedures
  • Treatment of traumatic haemorrhage
  • Management of epistaxis or gastrointestinal bleeding

Benefits of Tranexamic Acid

Effective Bleeding Control
Tranexamic acid works by competitively blocking the lysine binding sites on plasminogen, which prevents the formation of plasmin. This action effectively preserves the integrity of fibrin clots, ensuring that bleeding is controlled efficiently during critical periods of need.

Versatile Clinical Application
Beyond surgical use, Tranexamic Acid 500mg Tablet provides a non-hormonal option for women suffering from heavy menstrual cycles. It helps reduce the volume of blood loss without interfering with the natural hormonal cycle, offering a targeted approach to managing symptoms that significantly impact daily quality of life.

Side effects of Tranexamic Acid

While generally well-tolerated, Tranexamic Acid 500mg Tablet may cause gastrointestinal disturbances such as nausea, vomiting, or diarrhoea. These symptoms are typically dose-dependent and often subside with continued use or by taking the medication with food. Some individuals may experience visual disturbances, including changes in colour vision, which necessitates immediate medical consultation. Rare but serious adverse effects include thromboembolic events, such as deep vein thrombosis or pulmonary embolism, particularly in patients with pre-existing risk factors. Allergic skin reactions, including rashes, have been reported in sensitive individuals. If you notice any signs of swelling, chest pain, or sudden shortness of breath, seek emergency medical care immediately.

Side effectHow commonHow severeWhat to do
NauseaCommonMildTake with food.
Visual disturbancesRareModerateStop use and consult a doctor.
ThromboembolismVery rareSevereSeek emergency care.

How to manage side effects

Nausea

  • Take the dose with a meal or a glass of milk to reduce gastric irritation.

Visual disturbances

  • Discontinue the medication immediately and seek an urgent ophthalmological evaluation.

Thromboembolism

  • Stop the drug and seek immediate emergency medical attention for signs like chest pain or leg swelling.

How to use Tranexamic Acid

  • Swallow the tablet whole with a glass of water, do not crush or chew.
  • Take the medication exactly as prescribed by your healthcare provider.
  • For menstrual bleeding, start taking the tablets only when your period begins.
  • Do not exceed the maximum daily dose recommended by your doctor.
  • Maintain consistent hydration while taking this medication to support renal function.

Special population advice

Kidney impairment

  • Reduce dose based on serum creatinine levels.
  • Monitor renal function closely during therapy.

Liver impairment

  • No specific dose adjustment required.
  • Use with caution in severe hepatic disease.

Children

  • Dose based on body weight.
  • Use only for specific indications like haemophilia.

Elderly

  • Use with caution due to higher risk of cardiovascular events.
  • Monitor for signs of thrombosis.

How Tranexamic Acid works

Tranexamic acid acts as a competitive inhibitor of plasminogen activation. By binding to the lysine-binding sites of plasminogen and plasmin, it prevents the interaction of plasmin with fibrin. This inhibition stops the fibrinolytic process, thereby stabilizing existing clots and preventing premature breakdown of the haemostatic plug.

What if you miss or exceed a dose?

If you miss a dose

If you miss a dose of Tranexamic Acid 500mg Tablet, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose entirely. Do not take two doses at the same time to make up for a forgotten one, as this increases the risk of side effects.

In case of overdose

An overdose of Tranexamic Acid 500mg Tablet may lead to symptoms such as dizziness, headache, hypotension, and gastrointestinal distress. In severe cases, there is an increased risk of thromboembolic complications. If you suspect an overdose, contact your local poison control centre or seek emergency medical attention immediately, even if no symptoms are currently present.

AntidoteNo specific antidote

Management is supportive and symptomatic.

Gastric decontamination
Consider activated charcoal if ingestion was recent.
Hydration
Maintain adequate fluid intake to promote renal excretion.
Monitoring
Observe for signs of thromboembolism or seizures.
Supportive care
Manage hypotension or other symptoms as they arise.

Safety and precautions

When to avoid Tranexamic Acid

Do not take if you
  • Active thromboembolic disease

    Increased risk of life-threatening clots.

  • History of convulsions

    May lower the seizure threshold.

Use with caution
  • Renal impairment

    Requires dose reduction due to accumulation.

  • Haematuria

    Risk of ureteral obstruction due to clot formation.

  • Disseminated intravascular coagulation

    Use only under expert supervision.

  • Combined oral contraceptives

    Increased risk of venous thromboembolism.

Safety at a glance

AlcoholSafe

No specific interaction, but excessive alcohol may mask symptoms.

PregnancyConsult your doctor

Use only if clearly indicated and under medical supervision.

BreastfeedingSafe

Tranexamic acid is excreted in breast milk in small amounts; consult your doctor.

DrivingSafe

Usually does not affect driving, but avoid if you experience dizziness.

KidneyUse with caution

Dose adjustment is required in patients with renal impairment.

LiverSafe

No specific dose adjustment is typically required for liver disease.

AllergyUnsafe

Do not use if you have a known hypersensitivity to tranexamic acid.

ChildrenConsult your doctor

Use only under strict paediatric supervision for specific conditions.

ElderlyUse with caution

Monitor for increased risk of thromboembolic events.

Interactions

With other medicines

Combined oral contraceptives

Moderate

Changes the medicine’s effect

What can happen: Increased risk of venous thrombosis.

What to do: Avoid concurrent use or monitor closely for signs of clotting.

Factor IX complex concentrates

Major

Changes the medicine’s effect

What can happen: Increased risk of thrombosis.

What to do: Do not use together unless specifically directed by a haematologist.

Tretinoin

Moderate

Changes the medicine’s effect

What can happen: Potential for increased thrombotic risk.

What to do: Monitor patients closely for any signs of vascular complications.

With food and drink

  • None knownMinor

    No significant food interactions have been documented.

  • High-fat mealsMinor

    May slightly delay the rate of absorption without affecting overall bioavailability.

If you have another condition

  • Renal failure

    Requires dose adjustment to prevent toxicity.

  • Thrombophilia

    Contraindicated due to high risk of clotting.

Effect on laboratory tests

  • Coagulation profile

    May alter clotting times

    Inform the lab that you are taking an antifibrinolytic.

Quick tips

  • Inform your doctor if you have a history of blood clots or stroke.
  • Monitor for any changes in your vision and report them promptly.
  • This drug does not prevent pregnancy; use appropriate contraception if needed.
  • Keep a record of your bleeding patterns to help your doctor assess treatment efficacy.
  • Store the medication in a cool, dry place away from direct sunlight.

Counselling points

  • AdherenceImportant

    Take the medication exactly as directed for the duration specified.

  • Warning signsImportant

    Seek medical help if you experience leg pain, chest pain, or vision changes.

  • ContraceptionGood to know

    Discuss the use of hormonal birth control with your doctor.

  • HydrationOptional

    Drink plenty of water while on this medication.

Monitoring during treatment

Before starting

  • Renal function tests (serum creatinine)
  • Coagulation profile

During treatment

  • every month: Assess bleeding patterns and treatment response.

What is being watched

  • Serum creatinine
  • Blood pressure
  • Visual acuity

Pharmacokinetics

Absorption
Rapidly absorbed after oral administration.
Bioavailability
Approximately 30-50%.
Protein binding
About 3% to plasminogen.
Volume of distribution
9 to 12 litres.
Half-life
Approximately 2 to 3 hours.
Metabolism
Minimal hepatic metabolism.
Excretion
Primarily excreted unchanged in urine.
Onset / duration
Onset within 1-2 hours; duration 6-8 hours.

Fact box

Chemical class
Synthetic lysine analogue
Habit forming
No
Therapeutic class
Haemostatic agent
Action class
Plasminogen activation inhibitor
Storage
Store at room temperature between 20°C and 25°C. Keep in the original packaging, away from moisture, heat, and direct light. Keep out of reach of children.
ATC code
B02AA02
Pregnancy category
B

More information

Clinical Rationale for Use

Clinicians select Tranexamic Acid as a first-line therapy for non-hormonal management of menorrhagia because it addresses the underlying mechanism of excessive fibrinolysis. Unlike hormonal contraceptives, it does not alter the endocrine profile, making it suitable for patients who wish to conceive or those who have contraindications to exogenous hormones. In surgical settings, it is chosen for its proven ability to reduce the need for blood transfusions, thereby improving patient outcomes and reducing the risks associated with donor blood products.

Comparison with Alternatives

When compared to NSAIDs, which are also frequently prescribed for heavy menstrual bleeding, Tranexamic Acid demonstrates superior efficacy in reducing total menstrual blood loss volume. While NSAIDs work primarily by inhibiting prostaglandin synthesis in the endometrial tissue, Tranexamic Acid directly targets the plasminogen activation pathway to prevent clot breakdown. For patients who possess absolute contraindications to hormonal therapy or who wish to avoid progestin-related mood side effects, Tranexamic Acid serves as a safer alternative, providing a localized haemostatic effect without exerting systemic hormonal actions across the body.

Lifestyle and Treatment Expectations

Patients taking Tranexamic Acid should anticipate a gradual and noticeable reduction in menstrual blood loss over the initial few cycles of consistent treatment. It is essential to maintain a detailed diary recording heavy bleeding days and pad counts to allow the physician to accurately assess clinical efficacy and adjust the dosing regimen if necessary. Lifestyle modifications, such as maintaining optimal hydration, engaging in regular low-impact physical activity, and avoiding prolonged immobilization, are strongly recommended to help minimize the risk of venous thromboembolic events, which remains a critical clinical consideration during any antifibrinolytic therapy course.

Common Misconceptions

A frequent misconception among patients is that Tranexamic Acid acts as a systemic blood thinner because it relates to the blood clotting cascade. Patients often harbor fears that taking it will provoke spontaneous bleeding, whereas it is actually a potent antifibrinolytic agent that actively promotes clot stability and stops hemorrhage. Another prevalent myth is that it functions as an oral contraceptive or prevents pregnancy; it has no pharmacologic effect on ovulation, fertilization, or hormone regulation. Patients should be reassured that it is a targeted, safe, and highly effective therapeutic tool when administered strictly under professional medical supervision for its approved clinical indications.

References

  1. Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019. p. 676.Accessed
  2. Electronic Medicines Compendium. Tranexamic Acid 500mg Tablets, Summary of Product Characteristics.View sourceAccessed
  3. National Agency for Food and Drug Administration and Control. Trenaxa Summary of Product Characteristics.View sourceAccessed
  4. Medical Products Agency Sweden. Cyklo-f film-coated tablet Summary of Product Characteristics.View sourceAccessed
  5. European Medicines Agency. Referral procedure for antifibrinolytic medicines.View sourceAccessed

Frequently asked questions about Tranexamic Acid

Can I take Tranexamic Acid 500mg Tablet for every period?

It is intended for heavy menstrual bleeding as diagnosed by a doctor. Do not use it for routine cycles without medical advice.

Does Tranexamic Acid 500mg Tablet stop bleeding immediately?

It helps stabilize clots, but it is not an instant haemostatic agent for active, severe haemorrhage.

Is Tranexamic Acid 500mg Tablet a blood thinner?

No, it is the opposite. It is an antifibrinolytic that helps blood clot more effectively.

Can I take this with painkillers?

Generally yes, but consult your doctor to ensure there are no specific contraindications with your other medications.

What should I do if I experience vision changes?

Stop taking the medication and contact your ophthalmologist or primary care physician immediately.

Latest